US to pay $2.1b to Sanofi, GSK, in COVID-19 vaccine deal

The US government will pay $2.1 billion to Sanofi SA and GlaxoSmithKline Plc for COVID-19 vaccines to cover 50 million people and to underwrite the drug makers’ testing and manufacturing, the companies said on Friday.
The award is the biggest yet from ‘Operation Warp Speed’, the White House initiative aimed at accelerating access to vaccines and treatments to fight COVID-19, the respiratory disease caused by the coronavirus.